ANI Pharmaceuticals DSO Ratio 2011-2026 | ANIP

Annual DSO Ratio ANI Pharmaceuticals

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
114	123	170	189	147	127	117	121	130	105	113	152	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
189	105	134

Quarterly DSO Ratio ANI Pharmaceuticals

2025-Q3	2025-Q2	2025-Q1	2024-Q3	2024-Q2	2024-Q1	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
95.8	96.3	96.5	111	-	-	122	136	145	-	158	174	184	-	175	173	157	153	165	180	154	137	128	121	118	104	117	125	121	113	111	120	130	110	109	134	151	111	100	103	95.2	75	90.8	237	125	-	146	186	147	252	98.4	47.8	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
252	47.8	133

DSO Ratio of other stocks in the Biotechnology industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Benitec Biopharma BNTC	141	$ 10.98	-4.52 %	$ 452 M	USA
Ascendis Pharma A/S ASND	132	$ 221.88	-0.87 %	$ 5 B	Danmark
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	84.7	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	204	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	2.75 K	-	-1.52 %	$ 24.7 M	USA
Applied Genetic Technologies Corporation AGTC	0.114	-	-	$ 26.5 M	USA
Aeterna Zentaris AEZS	146	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
Acorda Therapeutics ACOR	48.3	-	-24.86 %	$ 820 K	USA
Albireo Pharma ALBO	14.7	-	-0.23 %	$ 916 M	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Assembly Biosciences ASMB	25.1	$ 28.46	3.45 %	$ 319 M	USA
Adverum Biotechnologies ADVM	222	-	-	$ 86.2 M	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Axsome Therapeutics AXSM	105	$ 156.92	-1.23 %	$ 7.81 B	USA
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
AbCellera Biologics ABCL	173	$ 3.4	-3.68 %	$ 1.02 B	Canada
BioDelivery Sciences International BDSI	115	-	-4.8 %	$ 255 M	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
BioMarin Pharmaceutical BMRN	88.9	$ 54.13	-1.64 %	$ 10.4 B	USA
Calithera Biosciences CALA	28.8	-	-10.95 %	$ 876 K	USA
Cara Therapeutics CARA	52.4	-	-3.03 %	$ 260 M	USA
ChemoCentryx CCXI	3.1	-	-	$ 3.74 B	USA
Compugen Ltd. CGEN	60.8	$ 2.09	-0.95 %	$ 195 M	Israel
Coherus BioSciences CHRS	559	$ 1.52	-5.59 %	$ 178 M	USA
Checkpoint Therapeutics CKPT	6.83	-	-	$ 169 M	USA
Clovis Oncology CLVS	65.5	-	-7.23 %	$ 13 M	USA
Aeglea BioTherapeutics AGLE	216	-	-	$ 1.01 B	USA
CureVac N.V. CVAC	13.6	-	-	$ 867 M	Germany
Corbus Pharmaceuticals Holdings CRBP	239	$ 8.6	-3.8 %	$ 115 M	USA
Curis CRIS	103	$ 0.77	1.89 %	$ 4.86 M	USA